Information Provided By: 
Fly News Breaks for December 10, 2019
UNH, DPLO
Dec 10, 2019 | 08:08 EDT
Deutsche Bank analyst George Hill does not expect another bidder to emerge for Diplomat Pharmacy (DPLO) given the "more than fair" valuation paid by UnitedHealth (UNH). The analyst, who has a Sell rating on Diplomat, also expects little regulatory pushback. Diplomat exits at 14.9 times the analyst's estimated 2020 EBITDA, which he notes is a "significant premium" to the standalone value of the company.
News For DPLO;UNH From the Last 2 Days
UNH
Apr 25, 2024 | 10:38 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
